Heda Ventures

Heda Ventures is an early-stage venture capital firm established in 2008 and located in San Jose, California. The firm specializes in investing in disruptive innovations within three primary sectors: biotech, healthcare, and IT technology. Heda Ventures targets seed-stage and early-stage companies, aiming to partner with innovative enterprises that exhibit significant growth potential. The firm is dedicated to supporting entrepreneurs and startups in developing transformative businesses that can create new market opportunities and drive meaningful change in their industries.

Lin Xie Ph.D

Managing Partner

Qiang Chen Ph.D

Venture Partner

Zheng Hongbin

CEO

9 past transactions

Immunowake

Series A in 2022
Immunowake is a biotechnology company dedicated to developing innovative therapies for patients who do not respond to current immunotherapies. The company aims to enhance the body's immune response against cancer by developing a universal cancer vaccine that generates safer and more effective bi-specific antibodies. By focusing on activating antigen-specific T-cells, Immunowake seeks to "wake up" the immune system, allowing it to identify and eliminate cancer cells more effectively. This approach not only strives to improve the efficacy of cancer treatments but also aims to reduce the associated toxicity for patients, ultimately enhancing their overall treatment experience.

LYNK Pharmaceuticals

Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Lianchuan Bio

Series B in 2020
Lianchuan Bio is a provider of a genomics and precision medicine platform based in China. The company focuses on the application of genetic technology across various healthcare scenarios. Its platform offers genome sequencing and genetic testing programs, allowing healthcare providers to accurately identify target genes. This capability facilitates significant advancements in clinical gene capture, enhancing the effectiveness of precision medicine.

Citcon

Series B in 2019
Citcon, founded in 2015 and headquartered in Silicon Valley, California, is a prominent payment technology company that facilitates mobile payments for global merchants. The company has developed a comprehensive platform that connects merchants with a wide array of mobile wallets and digital payment methods, enabling them to securely accept payments through web, mobile, and in-store channels. Citcon's infrastructure offers a user-friendly, contactless shopping experience that enhances security for both consumers and merchants. Through a single API suite and an integrated processing and fund settlement platform, businesses can efficiently manage domestic and international transactions. With a presence in the U.S., Canada, Europe, and Asia, Citcon serves millions of mobile wallet users, allowing them to shop at tens of thousands of participating merchants.

MuMec

Seed Round in 2018
MuMec, Inc. is a fabless startup based in Oakland, California, founded in 2014, specializing in the development of wireless transceiver technologies. The company focuses on creating solutions that significantly lower operating power for devices utilizing Bluetooth low energy and LoRa/Sigfox protocols. By enabling continuous operation of sensor node devices for extended periods—often using scavenged or battery power—MuMec's transceivers cater to various applications, including wireless audio streaming and Internet of Things (IoT) devices. Their innovations aim to enhance energy efficiency, allowing consumers to reduce power consumption and extend the battery life of various electronic devices.

Paragon Genomics

Series A in 2017
Paragon Genomics, Inc. is a biotechnology company based in South San Francisco, California, specializing in the development of polymerase chain reaction (PCR) reagents and targeted sequencing technologies. Founded in 2015, the company offers a range of products, including the CleanPlex targeted library kit, which facilitates multiplex PCR for next-generation sequencing (NGS). Its product lineup includes specialized panels such as the CleanPlex OncoZoom Panel for human DNA amplification, and specific panels for the BRCA1, BRCA2, and TP53 genes, all designed to enhance precision in genomic research. Paragon Genomics focuses on providing solutions that are rapid, sensitive, and cost-effective, addressing various applications in cancer research, liquid biopsy, biomarker discovery, and other areas essential to advancing precision medicine and diagnostics.

Symic Bio

Series B in 2017
Symic Biomedical, based in San Francisco, California, is a biotechnology company founded in 2012 that focuses on developing matrix regulator therapeutics. These therapeutics are designed to target and bind to matrix structures that are damaged due to injury or disease, thereby inhibiting pathological inflammatory responses. The company's research primarily addresses treatments for osteoarthritis and cardiovascular conditions, while also exploring applications in fibrosis, oncology, and diseases affecting the central nervous system. As a subsidiary of Symic Holdings, LLC, Symic Biomedical aims to provide innovative solutions in the healthcare sector through its specialized technology.

ScaleFlux

Venture Round in 2017
ScaleFlux, Inc. is a semiconductor company based in San Jose, California, with additional offices in Beijing, Shanghai, and Hangzhou, China. Founded in 2014, ScaleFlux specializes in computational storage solutions that enhance the efficiency of data centers and cloud infrastructure. The company focuses on helping clients manage data growth effectively, particularly in areas such as cloud computing, artificial intelligence, and enterprise applications. By integrating advanced compute engines with solid-state storage, ScaleFlux enables users to improve performance, efficiency, security, and scalability for data-intensive tasks. In addition to its storage and memory products, ScaleFlux offers fully validated firmware, software, and module designs to facilitate product adoption, ensuring customers can leverage optimized storage intelligence to enhance their infrastructure for computing and storage needs.

Citcon

Seed Round in 2017
Citcon, founded in 2015 and headquartered in Silicon Valley, California, is a prominent payment technology company that facilitates mobile payments for global merchants. The company has developed a comprehensive platform that connects merchants with a wide array of mobile wallets and digital payment methods, enabling them to securely accept payments through web, mobile, and in-store channels. Citcon's infrastructure offers a user-friendly, contactless shopping experience that enhances security for both consumers and merchants. Through a single API suite and an integrated processing and fund settlement platform, businesses can efficiently manage domestic and international transactions. With a presence in the U.S., Canada, Europe, and Asia, Citcon serves millions of mobile wallet users, allowing them to shop at tens of thousands of participating merchants.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.